Shows
Out of the Blue: An AJRCCM PodcastImpact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung DiseaseDr. Mohleen Kang chats with Dr. Kerri Johannson and Dr. Tamera Corte about their article, "Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease."2025-07-3146 minOut of the Blue: An AJRCCM PodcastImpact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung DiseaseDr. Mohleen Kang chats with Dr. Kerri Johannson and Dr. Tamera Corte about their article, "Impact of Environmental Exposures on the Development and Progression of Fibrotic Interstitial Lung Disease."2025-04-1745 min
ATS Breathe EasySocial Media for Early Career Professionals - Should I and How to Do it Well?Social media is taking on an ever increasing presence in medicine and academics. While it presents opportunities for outreach and networking, it also comes with many inherent challenges. In this podcast, we speak with seasoned ATS members who have successfully navigated social media in their professional spheres. Come join us for this low-key and fun discussion as they share their experiences and their perspectives on how early career professionals can leverage social media to advance their careers.2023-05-0258 min
The Lancet Respiratory Medicine in conversation withAntacid therapy in IPF: The Lancet Respiratory Medicine: June 23, 2017Kerri Johannson from the University of Calgary discusses why recent treatment guidelines on the use of antacid therapy in patients with IPF have caused controversy.Continue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv2017-06-2311 min
Listen to The Lancet Respiratory MedicineAntacid therapy in IPF: The Lancet Respiratory Medicine: June 23, 2017Kerri Johannson from the University of Calgary discusses why recent treatment guidelines on the use of antacid therapy in patients with IPF have caused controversy.1970-01-0111 min